These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1390319)

  • 41. Review of dietary intervention studies: effect on coronary events and on total mortality.
    Truswell AS
    Aust N Z J Med; 1994 Feb; 24(1):98-106. PubMed ID: 8002875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of cholesterol-lowering treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond.
    Katan MB
    Cardiology; 1990; 77 Suppl 4():8-13. PubMed ID: 2073675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized clinical trials in heart disease.
    JAMA; 1989 May; 261(20):2952-4. PubMed ID: 2654424
    [No Abstract]   [Full Text] [Related]  

  • 45. Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials.
    White CW
    Am J Med; 1998 Jul; 105(1A):63S-68S. PubMed ID: 9707270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholesterol lowering and CHD prevention: time to get on with it.
    Betteridge DJ
    Br J Clin Pract; 1994; 48(3):115-7. PubMed ID: 8031684
    [No Abstract]   [Full Text] [Related]  

  • 47. Does lowering serum cholesterol levels lower coronary heart disease risk?
    Rossouw JE; Rifkind BM
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):279-97. PubMed ID: 2192874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesterol reduction and clinical benefit. Are there limits to our expectations?
    Fager G; Wiklund O
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3527-33. PubMed ID: 9437202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary heart disease in hypertensives: a need to reduce cholesterol.
    Heyden S; Schneider KA; Fodor GJ
    Int J Epidemiol; 1988 Dec; 17(4):784-8. PubMed ID: 3066769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholesterol and cardiovascular disease: how strong is the evidence?
    LaRosa JC
    Clin Cardiol; 1992 Nov; 15(11):III2-7; discussion III8-9. PubMed ID: 1458693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of mortality from coronary heart disease with pravastatin.
    Tonkin AM; Ryan EW
    Biomed Pharmacother; 1999 Oct; 53(9):405-8. PubMed ID: 10554675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
    Grundy SM; Cleeman JI; Rifkind BM; Kuller LH
    Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Optimal serum cholesterol and efficacy of methods for lowering cholesterolemia].
    Emmerich J; Thomas D; Richard JL; Delahaye F; Bruckert E
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():59-65. PubMed ID: 1296546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lowering increased cholesterol--prolonging life?].
    Klepzig H; Kaltenbach M
    Versicherungsmedizin; 1992 Dec; 44(6):192-4. PubMed ID: 1475889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wholegrain cereals for coronary heart disease.
    Kelly SA; Summerbell CD; Brynes A; Whittaker V; Frost G
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005051. PubMed ID: 17443567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of high serum cholesterol and related disorders in patients at risk for coronary heart disease.
    Grundy SM
    Am J Med; 1997 Feb; 102(2A):15-22. PubMed ID: 9217581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary prevention of coronary heart disease: role of cholesterol control in the United States.
    Grundy SM
    J Intern Med; 1997 Apr; 241(4):295-306. PubMed ID: 9159601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of selenium supplementation on coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.
    Ju W; Li X; Li Z; Wu GR; Fu XF; Yang XM; Zhang XQ; Gao XB
    J Trace Elem Med Biol; 2017 Dec; 44():8-16. PubMed ID: 28965605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.